30 April 2021
This year’s Scientists’ Choice Award for Drug Discovery & Development Article of the Year went to an interview with Prof. Leo A. B Joosten, Radboudumc, detailing how Olink Proteomics multiplex immunoassay technology enabled identification of biomarkers to predict patient risk of COVID-19.
In this video, Dr. Andrea Ballagi, VP Sales and Marketing, Olink Proteomics, shares her thoughts on winning this prized award, why promoting customer success is important for Olink Proteomics and the scientific community, and how the company’s technology will help advance future drug discovery.
Read the winning article here: Clinical proteomics: Identifying biomarkers to predict patient risk of COVID-19